Select Page

European life sciences investment major LSP leads €32m VarmX Series B round


European life science and healthcare investor LSP has led a €32m Series B financing round for VarmX, a biotech company



Source link

About The Author

Leave a reply

Your email address will not be published. Required fields are marked *